Keywords: Rosiglitazone, Cognitive performance, Neuronal signaling, University of Texas, Avandia, GlaxoSmithKline

Research shows diabetes drug rosiglitazone improves memory

Article | 21 November 2012

Print This

Rosiglitazone, the active ingredient of GlaxoSmithKline’s diabetes drug Avandia, has shown promise as a way to improve cognitive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in